Correlation Between Eaton Vance and Franklin Genomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eaton Vance and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eaton Vance and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eaton Vance Enhanced and Franklin Genomic Advancements, you can compare the effects of market volatilities on Eaton Vance and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eaton Vance with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eaton Vance and Franklin Genomic.

Diversification Opportunities for Eaton Vance and Franklin Genomic

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Eaton and Franklin is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Eaton Vance Enhanced and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and Eaton Vance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eaton Vance Enhanced are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of Eaton Vance i.e., Eaton Vance and Franklin Genomic go up and down completely randomly.

Pair Corralation between Eaton Vance and Franklin Genomic

Considering the 90-day investment horizon Eaton Vance Enhanced is expected to generate 0.81 times more return on investment than Franklin Genomic. However, Eaton Vance Enhanced is 1.23 times less risky than Franklin Genomic. It trades about 0.15 of its potential returns per unit of risk. Franklin Genomic Advancements is currently generating about 0.09 per unit of risk. If you would invest  2,240  in Eaton Vance Enhanced on November 18, 2024 and sell it today you would earn a total of  209.00  from holding Eaton Vance Enhanced or generate 9.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eaton Vance Enhanced  vs.  Franklin Genomic Advancements

 Performance 
       Timeline  
Eaton Vance Enhanced 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eaton Vance Enhanced are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Eaton Vance may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Franklin Genomic Adv 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Genomic Advancements are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Franklin Genomic may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Eaton Vance and Franklin Genomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eaton Vance and Franklin Genomic

The main advantage of trading using opposite Eaton Vance and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eaton Vance position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.
The idea behind Eaton Vance Enhanced and Franklin Genomic Advancements pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities